Global Defibrillator Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Defibrillation is a common treatment for life-threatening cardiac dysrhythmias, ventricular fibrillation and pulseless ventricular tachycardia. Defibrillation consists of delivering a therapeutic dose of electrical energy to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training at all.

Published by: GIR (GlobalInfoResearch)

Catalog: Medical Devices

Publishing Date: Oct 2016

Single User License: USD 3480

Corporate Users License: USD 4680

Delivery time: 24 hours

Pages: 114

Tables and Figures: 136

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=1060[url]

Scope of the Report:

This report focuses on the Defibrillator in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Medtronic

St. Jude Medical

Boston Scientific

Biotronik

Physio-Control

Nihon Kohden Corporation

Zoll Medical

Cardiac Science

Philips Healthcare

PRIMEDIC

Schiller

Sorin Group

HeartSine Technologies

Defibtech

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle East and...